Antibacterial drugs for community-acquired pneumonia.
Med Lett Drugs Ther
; 63(1616): 10-14, 2021 01 25.
Article
in English
| MEDLINE | ID: covidwho-1052595
Keywords
Avelox; Baxdela; Biaxin; COVID-19; Ceftin; Chlamydophila pneumoniae; Clavulin; Clostridiodes difficile; Clostridium difficile; Doxy; Haemophilus influenzae; Mycoplasma pneumoniae; Nuzyra; Pseudomonas aeruginosa; Streptococcus pneumoniae; Unasyn; Vibramycin; Xenleta; Zithromax; adverse effects; amoxicillin; amoxicillin/clavulanate; ampicillin/sulbactam; antibacterials; azithromycin; cefepime; cefotaxime; cefpodoxime; ceftaroline; ceftriaxone; cefuroxime; clarithromycin; delafloxacin; dosage; doxycycline; drug interactions; efficacy; fluoroquinolones; gemifloxacin; influenza; lefamulin; levofloxacin; linezolid; methicillin-resistant staphylococcus aureus; moxifloxacin; omadacycline; penicillin; piperacillin/tazobactam; pregnancy; safety; tetracyclines; vancomycin
Search on Google
Collection:
International databases
Database:
MEDLINE
Main subject:
Community-Acquired Infections
/
Pneumonia, Bacterial
/
Anti-Bacterial Agents
Type of study:
Diagnostic study
/
Observational study
Limits:
Humans
Language:
English
Journal:
Med Lett Drugs Ther
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS